These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10671224)

  • 1. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
    Li-Weber M; Laur O; Dern K; Krammer PH
    Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression.
    Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH
    Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
    Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Ju ST
    J Immunol; 1998 Oct; 161(7):3469-73. PubMed ID: 9759866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-inflammatory sesquiterpene lactone parthenolide suppresses CD95-mediated activation-induced-cell-death in T-cells.
    Li-Weber M; Giaisi M; Baumann S; Treiber MK; Krammer PH
    Cell Death Differ; 2002 Nov; 9(11):1256-65. PubMed ID: 12404125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
    Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
    Westendorp MO; Frank R; Ochsenbauer C; Stricker K; Dhein J; Walczak H; Debatin KM; Krammer PH
    Nature; 1995 Jun; 375(6531):497-500. PubMed ID: 7539892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.
    Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS
    Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
    Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
    Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors.
    Ott M; Lovett JL; Mueller L; Verdin E
    J Immunol; 1998 Mar; 160(6):2872-80. PubMed ID: 9510190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unexpected role for FosB in activation-induced cell death of T cells.
    Baumann S; Hess J; Eichhorst ST; Krueger A; Angel P; Krammer PH; Kirchhoff S
    Oncogene; 2003 Mar; 22(9):1333-9. PubMed ID: 12618758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes.
    Norian LA; Latinis KM; Koretzky GA
    J Immunol; 1998 Aug; 161(3):1078-82. PubMed ID: 9686564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IKK antagonizes CD95 ligation-mediated apoptosis by regulating NF-kappaB activity.
    Wang J; Minemoto Y; Lin A; Li Y; Shen B; Zhang J
    Mol Immunol; 2007 Mar; 44(8):2139-43. PubMed ID: 17118453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB.
    Okamoto K; Fujisawa J; Reth M; Yonehara S
    Genes Cells; 2006 Feb; 11(2):177-91. PubMed ID: 16436054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
    Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
    J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-kappa B.
    Ivanov VN; Lee RK; Podack ER; Malek TR
    Oncogene; 1997 May; 14(20):2455-64. PubMed ID: 9188860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.